ReposiTrak, Inc. (NASDAQ: TRAK) reported that Chief Executive Officer Randall K. Fields sold a total of 7,500 shares of the company’s common stock over a three-day span in early March 2026, according to a Securities and Exchange Commission filing.
The transactions, which occurred between March 2 and March 4, 2026, generated aggregate proceeds of $64,795, with execution prices falling between $8.55 and $8.75 per share. The block sizes and prices by date were disclosed as follows:
- March 2, 2026 - 2,500 shares sold at $8.75 per share.
- March 3, 2026 - 2,500 shares sold at prices ranging from $8.50 to $8.60 per share.
- March 4, 2026 - 2,500 shares sold at prices ranging from $8.50 to $8.75 per share, for a weighted average price of $8.6182.
The sales were carried out from stock held by RK Fields Charitable 2022, LLC and were executed automatically under a Rule 10b5-1 trading plan. Fields put the plan in place in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, which is the managing member of RK Fields Charitable 2022, LLC. The filing notes that the trading plan was established to satisfy certain charitable commitments.
Following these dispositions, Fields retains a significant stake in ReposiTrak through multiple holdings. He indirectly holds 92,500 shares via RK Fields Charitable 2022, LLC and directly owns 3,483,955 shares. Additional indirect holdings include 615,260 shares of common stock and 169,797 shares of Series B Preferred Stock through Riverview Financial Corp.; 30,667 shares of common stock and 3,704 shares of Series B Preferred Stock held through his spouse; and 333,643 shares of common stock held through Fields Management, Inc.
The insider-selling activity comes as TRAK shares have been trading near their 52-week low of $8.11, and the stock has declined 56% over the past year.
ReposiTrak’s recent corporate disclosures also highlighted a number of operational and shareholder developments. The company described a patent-pending system designed to automatically detect and correct errors in food traceability data. In that disclosure, the company stated that traceability records frequently exhibit an average error rate of 40% - a figure that encompasses issues such as missing lot codes and inaccurate product identifiers.
In addition to product innovation, ReposiTrak announced an expansion of its strategic relationship with the National Grocers Association. The company said the partnership will concentrate on supporting independent grocers with regulatory compliance and efforts to improve financial performance by offering education, training and additional resources for compliance management.
On the shareholder returns front, ReposiTrak declared a quarterly cash dividend of $0.02 per share, equivalent to $0.08 on an annualized basis. The company indicated that payments are scheduled around February 13, 2025, and that future dividends are expected to be paid within 45 days after each fiscal quarter ends.
Financial metrics cited in company-related analysis note a Piotroski Score of 9 and gross profit margins of 85%. An InvestingPro assessment included in the disclosures characterized the stock as appearing undervalued at current levels and referenced availability of additional analytical content, including 11 ProTips and comprehensive financial metrics on the platform.
Taken together, the SEC filing on Fields’ sales and the company’s operating updates provide a snapshot of recent insider activity, product development, an industry partnership and a modest cash dividend, all occurring while the stock trades near its yearlong low.